Category: Life Sciences
Berkley Life Sciences and the law firm of Bowman and Brooke LLP would like to invite you to a live webinar titled “2018 Life Science Litigation Recap & What’s Coming in 2019.”
Kim Schmid, Firm Vice Chair and Executive Managing Partner at Bowman and Brooke, and Cindy Khin, Life Sciences Casualty Resolution Director at Berkley Life Sciences, will look back on 2018 and examine litigation trends as well as review significant jury verdicts, settlements and noteworthy rulings. They will preview 2019 with an overview of FDA developments, litigation trends and forecasts for 2019.
Click here to register and learn about these newsworthy topics from two of the life science industry's leading experts.
Berkley Life Sciences First to Fill Critical Political Risk Insurance Gap for Life Science Companies
Berkley Life Sciences, a W. R. Berkley Company® has introduced political risk insurance for life science companies, a new, essential coverage exclusively crafted to address life science exposures faced by customers with assets or operations overseas. (more…)
Hedy Linette Ranieri, VP and Chief Resolution Officer, Berkley Life Sciences will speak at the CLM Annual Conference, which will be held at the Hilton Orlando Bonnet Creek, April 6-8. Her session is titled, “Diversity & Inclusion - M2: Motivating Millennials and B3: Bridling the Baby Boomers.”
Cynthia Khin, Director, Berkley Life Sciences will speak at the CLM Annual Conference, which will be held at the Hilton Orlando Bonnet Creek, April 6-8. Her session is titled, “Alternative Dispute Resolution - Increasing the Success and Effectiveness of Mediations.”
Bowman & Brooke Discuss “The Final Product – Production of Electronically Stored Information (“ESI”)”
Bowman and Brooke LLP's Discovery Coordination and eDiscovery Practice group presents the third and final article of a three-part series of articles on discovery and document management. (more…)
Berkley Life Sciences Vice President and Chief Claims Officer, Hedy "Linette" Ranieri will speak at the 2015 New York Claims & Litigation Management (CLM) Conference. Ms. Ranieri will review "The 2015 CLM National Management Study - Highlights and Observations". The event will take place in New York at the New York Marriott Downtown on December 3rd. (more…)
Bowman and Brooke LLP's Discovery Coordination and eDiscovery Practice group presents the second of a three-part series of articles on discovery and document management. (more…)
Berkley Life Sciences Fleet Safety Newsletter Article Series – Article 1 Why do I need a fleet management program?
Did you know that a motor vehicle crash occurs every 5 seconds and every 12 minutes someone dies in a motor vehicle crash?1 Your company’s potential exposure to car accidents increases with the number of drivers, the number of vehicles, and the number of miles driven. With these odds, you want to be sure you have a solid program in place to manage your fleet and drivers and reduce your exposure. (more…)
Bowman and Brooke LLP's Discovery Coordination and eDiscovery Practice group presents the first of a three-part series of articles on discovery and document management.
Article 1, "Effective Litigation Holds," prepares you for implementing effective steps to preserve relevant information at the onset of litigation. It educates you about the new Fed. R. Civ. P. 37(e) on sanctions for "Failure to Preserve Electronically Stored Information," and the "reasonable steps" federal courts will expect you to take in order to avoid sanctions. (more…)
This is a question many life science companies have been asking themselves over the past couple of years as more data breaches are in the news. Even the federal government is at risk: in 2012, the United States Food and Drug Administration (FDA) detected a breach of their information systems that resulted in the theft of personal information included by life science companies in their product submissions. The FDA quickly made the necessary adjustments but the submitting life sciences companies were concerned that the cyber criminals were after more than just personal information and were looking for data on clinical trials, intellectual property or more. The FDA defines cyber security as the “process of preventing unauthorized modification, misuse, or denial of use, or the unauthorized use of information that is stored, accessed, or transferred from a medical device to an external recipient.” (more…)